[Federal Register Volume 78, Number 135 (Monday, July 15, 2013)]
[Notices]
[Page 42088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-16823]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0001]


Anesthetic and Analgesic Drug Products Advisory Committee; 
Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Anesthetic and Analgesic Drug Products 
Advisory Committee scheduled for July 17, 2013, is cancelled. This 
meeting was announced in the Federal Register of May 17, 2013 (78 FR 
29142 to 29143). This meeting has been canceled due to new information 
submitted to the application. The Agency intends to continue evaluating 
the application and, as needed, will announce future meeting dates in 
the Federal Register.

FOR FURTHER INFORMATION CONTACT: Caleb Briggs, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533, email: [email protected], or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), and follow the prompts to the desired center or 
product area. Please call the Information Line for up-to-date 
information on this meeting.

    Dated: July 9, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-16823 Filed 7-12-13; 8:45 am]
BILLING CODE 4160-01-P